If youre considering starting a GLP-1 or already taking one and struggling with GI symptoms, getting proper medical support can make a meaningful difference
If youve been following the news around medications like semaglutide (Ozempic, Wegovy) , tirzepatide (Mounjaro, Zepbound) , and the newer retatrutide (still in clinical trials) , youve probably heard about their impressive results
Efficacy Comparison In adults with overweight or obesity (and at least one related health condition), semaglutide treatment resulted in significant, lasting weight loss over 104 weeks compared to a placebo
CrossRef Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation Fabiana Crispo, Antonio Vassallo, Immacolata Faraone, Alessandro Santarsiere, Lucia Chiummiento, Mara Martinelli, Nicoletta Cascelli, Xavier Fernndez-Busquets, Rocchina Miglionico, Ilaria Nigro, Carla Caddeo, Maria Francesca Armentano International Journal of Molecular Sciences .2025
For diabetics, long-term use is in the minds of 65%, while 27% plan to switch on and off
Yes, many patients successfully switch between GLP-1 agonists and GIP/GLP-1 agonists when tolerability improves the fit